Europe Breast Imaging Market

Europe Breast Imaging Market Size (2023 to 2028)

The size of the Breast Imaging market in Europe is anticipated to grow at 8.64% CAGR from 2023 to 2028, and it is valued at USD 0.92 billion in 2023 and is expected to reach USD 1.40 billion by 2028.

Increasing commercialization of healthcare system because of the rise in the number of people undergoing advanced treatments owing to schemes like statutory health insurance, enhancements in breast imaging modalities, greater extent of public funding in Europe’s healthcare system, the higher occurrence rate of breast cancer alongside government backing for cancer prevention are majorly accelerating the breast imaging market in Europe.

Emerging economies of the European countries like Germany, Spain, France, the UK, Italy, and remaining countries, are expected to provide opportunities for the growth of the Europe Breast imaging market. However, due to increasing healthcare expenditures in the United Kingdom resulting in product and service portfolio expansion, which is likely to fuel the growth of the Breast Imaging market in the region, it will impact the growth of the European breast imaging market during the forecast period.

The evolution of advanced imaging systems like nuclear imaging, ultrasound, MRI, near-infra-red optical imaging, bioelectric imaging, and the changes in reimbursement policies are the factors anticipated to advance the growth opportunities for the Europe Breast imaging market. Furthermore, the increase in private and government investments to develop innovative and advanced breast imaging technologies due to the growing demand for breast cancer screenings boosts the European breast imaging market.

Certain limitations are opposing the growth of the European breast imaging market. They are the high cost of breast imaging systems and budget restrictions, and patients may face psychological health issues due to radiation exposure, expensive installation, and maintenance costs.

This research report on the European Breast Imaging Market has been segmented and sub-segmented into the following categories:

By Technology:

• Ionizing Technologies
  • Mammography
  • Digital Mammography
  • 3D Mammography
  • Molecular Breast-Specific Gamma Imaging (MBI/BSGI)
  • Positron Emission Tomography and Computed Tomography (PET-CT)
  • Cone-Beam Computed Tomography (CBCT)
  • Positron Emission Mammography (PEM)
• Non-ionizing Technologies
  • Breast MRI
  • Breast Ultrasound
  • Automated Whole-Breast Ultrasound (AWBU)
  • Breast Thermography
  • Optical Imaging

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Regionally, Europe held the second-largest market share due to the increased expenditure in developing futuristic technologies and rising awareness amongst patients. In addition, the emerging economies in the region, such as Germany, the United Kingdom, Spain, France, Italy, and the rest of Europe, are projected to fuel the expansion of the European breast imaging market.

The UK accounted for the largest share of the European breast imaging market and is more likely to continue its growth during the forecast period. Although the market growth is attributed to the increase in healthcare in the UK, resulting in product and service portfolio expansions, the growth of the breast imaging market in the area anticipated to fuel, throughout the projected period, will affect the growth of the European breast imagery market.

On the other hand, the German breast imaging market is expected to witness a significant share in the European market during the forecast period. The market growth is driven by the availability of advanced healthcare infrastructure, growing healthcare spending, and favorable reimbursement policies.

The French government announced the approval of the "Ma santé 2022" plan in July 2019 to reform the country's healthcare system. The government aimed to expand the number of medical experts and equip hospitals and local health care facilities to offer quality treatment under this strategy. In addition, such screening programs and activities are projected to raise awareness about breast cancer detection and treatment, therefore supporting the breast imaging market's growth.

Furthermore, in many states, like the United Kingdom, mammograms screening is digital, providing improved accuracy, quality, and greater efficiency. Digital mammography, therefore, becomes the favored screening method, even if the cost of new equipment is six times greater than older systems. Such market growth provides benefits throughout the predicted time.

KEY MARKET PLAYERS:

Some of the prominent companies leading the Europe Breast Imaging Market profiled in the report are Hologic, Inc., GE Healthcare, Siemens Healthcare, Philips Healthcare, Fujifilm Holdings Corporation Gamma Medica, Inc., Toshiba Corporation, Sonocine, Inc., Aurora Imaging Technology, Inc., and Dilon Technologies, Inc.